Previous work had suggested pausing Bruton tyrosine kinase (BTK) inhibitors before COVID-19 vaccination might boost immunity ...

FDA clears Nurix Therapeutics, Inc.'s GS-6791 for inflammatory disorders; Nurix earns $5M milestone from Gilead. Click for my ...

Researchers conducted the IMPROVE trial to evaluate whether a 3-week pause in BTK inhibitor use would improve immunity after COVID-19 booster vaccination without negatively affecting disease control ...

"As a truck driver, I use cardboard between palletized freight loads to try and protect the shipment while traveling, but ...

Plans to spray for spongy moths in five Minnesota counties have been scrapped after the federal funding for the aerial ...

Spongy moths are a destructive and invasive forest pest whose presence threatens forest health, according to the MDA.

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Annual Meeting Clinical Trials Plenary Session, Sanofi presented data on tolebrutinib in patients with non-relapsing ...

Azerbaijan and Georgia are good neighbors and strategic allies, sharing a high degree of mutual trust that enables vital ...

The Minnesota Department of Agriculture planned to apply an insecticide called Btk to 12 areas throughout the state to fight the spongy moth, whose voracious appetite is devastating to forests. But ...

SAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive ...